PGAP3 p.Pro276Leu
c.827C>T · rs750093817 · VCV426134
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9295 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.669 | pathogenic-leaning |
| SaProt | LLR -15.01 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>T here scores Δ0.29 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.3, phastCons 1 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 15 kb · p 0.63 · regional, not allelic |
| Overall | ||
| CADD | 29.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.0126% | 7,948 |
| Remaining individualsnot grpmax-eligible | 0.00642% | 15,573 |
| European (non-Finnish)grpmax | 0.00586% | 17,065 |
| East Asian | 0.00224% | 44,658 |
| Admixed American | 0.0017% | 58,722 |
| South Asian | 0.00112% | 89,516 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PGAP3
- Protein
- p.Pro276Leu
- Coding
- c.827C>T
- MANE Select
- NM_033419
- dbSNP
- rs750093817
- Type
- single nucleotide variant
- Location
- chr17:39673123 (GRCh38)
- Gene constraint
- LOEUF 1.147 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 93.17
Disease context
hyperphosphatasia with intellectual disability syndrome 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Hyperphosphatasia-intellectual disability syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- PGAP3 p.Pro276= Likely benign ★ same residue
- PGAP3 c.558-10G>A Pathogenic/Likely pathogenic ★★ same condition
- PGAP3 c.694+1G>A Pathogenic ★★ same condition
- PGAP3 p.Asp305Gly Pathogenic/Likely pathogenic ★★ same condition
- PGAP3 p.Gln89Ter Pathogenic ★★ same condition
- PGAP3 p.Glu37Ter Pathogenic ★★ same condition
- PGAP3 p.His284Arg Pathogenic/Likely pathogenic ★★ ⚠ same condition
- PGAP3 p.His284Tyr Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pgap3-p-pro276leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown